Magnetic bypass: a new tool against obesity and diabetes?
NCT ID NCT06467955
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new magnetic device (MagDI System) that creates a connection between the duodenum and ileum, bypassing part of the small intestine. The goal is to help with weight loss and blood sugar control in 60 adults with obesity and type 2 diabetes. Researchers are checking if the procedure is safe and works as intended.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Magnetic compression device (MagDI System) to create a small bowel bypass
What this could lead to
If successful, this could offer a less invasive surgical option for weight loss and type 2 diabetes control.
What could go wrong
This is an early feasibility study with only 60 participants. The device may fail to create a lasting bypass, or serious complications like bowel perforation or obstruction could occur.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
McGill University
Montreal, Quebec, H3A 0G4, Canada
-
University of Toronto
Toronto, Ontario, Canada
-
Westmount Square Surgical Center
Westmount, Quebec, H3Z 2P9, Canada